PhaseBio(美國)

PhaseBio

美國PhaseBiowww.phasebio.com作為一家開發(fā)治療糖尿病、代謝性疾病和心血管疾病等藥物臨床階段的生物技術(shù)私人企業(yè)——PhaseBio藥物有限公司PhaseBioisaclinical-stagebiopharmaceuticalcompanycommittedtodevelopingnewandimproveddrugswithaninitialfocus onendocrine,metabolicandcardiovasculardisease.Thecompanyusesaproprietaryclassofrecombinantbiopolymerscalledelastin-likepolymers(ELPs)toimprovethestability,bioavailability,activityandeaseofadministrationofproteinsandpeptidesthathavebeenshowntobeclinicallyactivewiththegoalofachievinggreaterdrugpotency,fewersideeffectsandbetterpatientcompliance.TheELPtechnologywasfirstdevelopedbyAshutoshChilkoti,Ph.D.,ProfessorofBiomedicalEngineeringatDukeUniversityandfurtherenhancedbyPhaseBioscientiststocreatelongactingbiopharmaceuticals.PhaseBiohastwoleadprograms.OurfirstleadcandidateGlymera,iscurrentlybeingevaluatedinhumansforthetreatmentofhyp